Cargando…
Focus on Key Issues in Immune Thrombotic Thrombocytopenic Purpura: Italian Experience of Six Centers
Immune-mediated thrombotic thrombocytopenic purpura is a rare and challenging hematological disease caused by the antibody anti-ADAMTS13. Though the mortality rate has decreased considerably in recent years, fatalities still remain unacceptable. This study aimed at further adding to the existing kno...
Autores principales: | Tiscia, Giovanni, Sartori, Maria Teresa, Giuffrida, Gaetano, Ostuni, Angelo, Cascavilla, Nicola, Nicolosi, Daniela, Battista, Cosima, Santeramo, Teresa Maria, Melillo, Lorella, Giordano, Giulio, Cappucci, Filomena, Fischetti, Lucia, Chinni, Elena, Tarantini, Giuseppe, Cerbo, Anna, Bertomoro, Antonella, Fabris, Fabrizio, Grandone, Elvira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658151/ https://www.ncbi.nlm.nih.gov/pubmed/34884404 http://dx.doi.org/10.3390/jcm10235702 |
Ejemplares similares
-
Reduction of ADAMTS13 Levels Predicts Mortality in SARS-CoV-2 Patients
por: Tiscia, Giovanni L., et al.
Publicado: (2020) -
The Prognostic Value of ADAMTS-13 and von Willebrand Factor in COVID-19 Patients: Prospective Evaluation by Care Setting
por: Tiscia, Giovanni, et al.
Publicado: (2021) -
Immune Thrombocytopenic Purpura Cases Following COVID-19 Vaccination
por: Condorelli, Annalisa, et al.
Publicado: (2021) -
Clinical Utility of Antithrombotic Prophylaxis in ART Procedures: An Italian Experience
por: Grandone, Elvira, et al.
Publicado: (2014) -
Obstetric outcomes in pregnant COVID-19 women: the imbalance of von Willebrand factor and ADAMTS13 axis
por: Grandone, Elvira, et al.
Publicado: (2022)